These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 9990772)

  • 21. Treatment of diabetic foot ulcers using cultured allogeneic keratinocytes--a pilot study.
    You HJ; Han SK; Lee JW; Chang H
    Wound Repair Regen; 2012; 20(4):491-9. PubMed ID: 22672334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dermagraft, a bioengineered human dermal equivalent for the treatment of chronic nonhealing diabetic foot ulcer.
    Marston WA
    Expert Rev Med Devices; 2004 Sep; 1(1):21-31. PubMed ID: 16293007
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Allogeneic Transplantation of an Adipose-Derived Stem Cell Sheet Combined With Artificial Skin Accelerates Wound Healing in a Rat Wound Model of Type 2 Diabetes and Obesity.
    Kato Y; Iwata T; Morikawa S; Yamato M; Okano T; Uchigata Y
    Diabetes; 2015 Aug; 64(8):2723-34. PubMed ID: 25795216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The use of cultured dermis in the treatment of diabetic foot ulcers.
    Grey JE; Lowe G; Bale S; Harding KG
    J Wound Care; 1998 Jul; 7(7):324-5. PubMed ID: 9791355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Meshed skin graft versus split thickness skin graft in diabetic ulcer coverage.
    Puttirutvong P
    J Med Assoc Thai; 2004 Jan; 87(1):66-72. PubMed ID: 14971537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Wound care: the role of advanced wound-healing technologies.
    Wu SC; Marston W; Armstrong DG
    J Am Podiatr Med Assoc; 2010; 100(5):385-94. PubMed ID: 20847352
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Autologous biograft and mesenchymal stem cells in treatment of the diabetic foot.
    Vojtassák J; Danisovic L; Kubes M; Bakos D; Jarábek L; Ulicná M; Blasko M
    Neuro Endocrinol Lett; 2006 Dec; 27 Suppl 2():134-7. PubMed ID: 17159798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Failure rates of artificial dermis products in treatment of diabetic foot ulcer: A systematic review and network meta-analysis.
    Tchero H; Herlin C; Bekara F; Kangambega P; Sergiu F; Teot L
    Wound Repair Regen; 2017 Aug; 25(4):691-696. PubMed ID: 28597935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth factors secreted by fibroblasts: role in healing diabetic foot ulcers.
    Mansbridge JN; Liu K; Pinney RE; Patch R; Ratcliffe A; Naughton GK
    Diabetes Obes Metab; 1999 Sep; 1(5):265-79. PubMed ID: 11225638
    [No Abstract]   [Full Text] [Related]  

  • 30. An overview of autologous skin grafts and advanced biologics for the diabetic foot.
    Ramanujam CL; Zgonis T
    Clin Podiatr Med Surg; 2012 Jul; 29(3):435-41. PubMed ID: 22727383
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effects of artificial dermis and vascular endothelial growth factor concentration gradient on wound healing in diabetic porcine model.
    Tsui HY; Liu YC; Yan X; Lin Y; Xu Y; Tan Q
    Growth Factors; 2017 Dec; 35(6):216-224. PubMed ID: 29447490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pinch graft harvesting technique for surgical closure of the diabetic foot.
    Ramanujam CL; Zgonis T
    Clin Podiatr Med Surg; 2012 Oct; 29(4):585-8. PubMed ID: 23044064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of Apligraf in acute wounds.
    Kirsner RS
    J Dermatol; 1998 Dec; 25(12):805-11. PubMed ID: 9990773
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Favorable result of the use of bioplastic material for closing an ulcerous defect in patient with diabetic foot syndrome].
    Zinov'ev EV; Almazov IA; Osmanov KF; Rakhmatullin RR
    Vestn Khir Im I I Grek; 2014; 173(6):73-4. PubMed ID: 25823317
    [No Abstract]   [Full Text] [Related]  

  • 35. An exploratory clinical study on the safety and efficacy of an autologous fibroblast-seeded artificial skin cultured with animal product-free medium in patients with diabetic foot ulcers.
    Morimoto N; Ito T; Takemoto S; Katakami M; Kanda N; Tada H; Tanaka S; Teramukai S; Kawai K; Nakamura Y; Kasai Y; Masayuki Y; Maekawa T; Shimizu A; Suzuki S
    Int Wound J; 2014 Apr; 11(2):183-9. PubMed ID: 22958543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Long-Term Outcomes Following the Application of Intralesional Epidermal Growth Factor in Patients With Diabetic Foot Ulcers.
    Kahraman M; Misir A; Kizkapan TB; Ozcamdalli M; Uzun E; Mutlu M
    J Foot Ankle Surg; 2019 Mar; 58(2):282-287. PubMed ID: 30612874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Criteria of efficacy of skin-fat flap transplantation in the treatment of large wound defects of foot in patients with diabetes mellitus].
    Sviridov NV
    Klin Khir; 2011 Feb; (2):70-1. PubMed ID: 21548335
    [No Abstract]   [Full Text] [Related]  

  • 38. Apligraf living skin equivalent for healing venous and chronic wounds.
    Sibbald RG
    J Cutan Med Surg; 1998 Dec; 3 Suppl 1():S1-24-8. PubMed ID: 10082604
    [No Abstract]   [Full Text] [Related]  

  • 39. The role of collagen bioscaffolds, foamed collagen, and living skin equivalents in wound healing.
    Landsman A; Taft D; Riemer K
    Clin Podiatr Med Surg; 2009 Oct; 26(4):525-33. PubMed ID: 19778686
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discussion.
    J Vasc Surg; 2014 Jun; 59(6):1663. PubMed ID: 24518608
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.